Working with purpose
Our vision—to enable normal lives for people with autoimmune diseases—is our daily motivator.
We are a clinical-stage immunology company, dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in anti FcRn technology, we are developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.
WHAT INSPIRES US
Immunovant’s two investigational products, IMVT-1402 and batoclimab, are novel, fully human, monoclonal antibodies that target FcRn and may reduce harmful immunoglobulin G (IgG) autoantibodies, which are common causes of autoimmune disease. We believe that both product candidates have the potential to address a variety of IgG-mediated autoimmune diseases as subcutaneous injections with dosing that may be tailored, based on disease stage and severity.
OUR VISION AND VALUES
Love Trailblazing
We are developing FcRn-targeted therapies that may help transform care for people with autoimmune diseases by delivering a more targeted approach than traditional broad-spectrum immunosuppressive agents in a subcutaneous formulation.
Bolder Faster
Our agile structure allows for technical rigor and speed, and our curiosity helps us uncover new approaches and adapt to new opportunities.
All Voices
We are scientists, clinicians, biopharma veterans, and entrepreneurs. Above all, we are passionate about creating value and believe that our collective voices bring new, powerful ideas to life.
Working with purpose
Our vision—to enable normal lives for people with autoimmune diseases—is our daily motivator.
Love Trailblazing
We are developing FcRn-targeted therapies that may help transform care for people with autoimmune diseases by delivering a more targeted approach than traditional broad-spectrum immunosuppressive agents in a subcutaneous formulation.
Bolder Faster
Our agile structure allows for technical rigor and speed, and our curiosity helps us uncover new approaches and adapt to new opportunities.
All Voices
We are scientists, clinicians, biopharma veterans, and entrepreneurs. Above all, we are passionate about creating value and believe that our collective voices bring new, powerful ideas to life.